The Mount Sinai Hospital Accomplishments in 2014
Tuesday, December 30, 2014
The Mount Sinai Hospital has had many successes this year that merit recognition as we close the year.
The Mount Sinai Hospital now ranks 16th out of approximately 5,000 hospitals nationwide – a U.S. News & World Report Honor Roll Hospital. We continue to see unparalleled growth in many quaternary care services and have experienced tremendous benefits and growth related to the creation of our Health System.
We undertook several major projects this year to improve our safety, quality, and efficiency:
- The first phase of the state-of-the-art Lauder Cardiovascular Center on GP1 opened this month for ambulatory cardiology and vascular surgery office practice, with major diagnostics and imaging coming in 2015;
- A 20-bed Observation Unit opened in February. The Rapid Evaluation and Treatment Unit (RETU) has cared for more than 4,500 patients, and avoided at least 450 re-admissions to the Hospital;
- The new building at Mount Sinai Queens continues to make rapid progress, with the expected opening of a new, expanded Emergency Department in late 2015, and seven new operating rooms, imaging, and office suites opening in 2016;
- We consolidated all preoperative evaluation and testing services on GP2;
- KP4 was extensively renovated to enhance the patient experience for women’s oncology services; and
- A centralized Admitting and Bed Management department was opened on GP2, and has greatly enhanced patient throughput and communication.
In July, The Mount Sinai Hospital received its third consecutive Magnet Recognition Program® designation from the American Nurses Credentialing Center (ANCC), and additionally, Mount Sinai Queens received a first-time Magnet designation. Fewer than eight percent of hospitals nationwide have received this honor. In January 2014, Mount Sinai’s Coronary Care Unit (CCU) was awarded the prestigious Beacon Award for Excellence from the American Association of Critical-Care Nurses. The Beacon Award signifies exceptional care through improved outcomes, greater overall satisfaction, a supportive work environment and collaboration between colleagues and leaders.
There were substantial improvements in Hospital-wide infection rates from 2013 to 2014: central line associated bacteremia rate per 1,000 patient days decreased from 1.0 to 0.6; in the ICUs, the rate decreased from 0.8 to 0.5; the CABG surgical site infection rate decreased from 3.3% to 2.6%; and the MRSA infection rate per 10,000 patient days decreased from 1.8 to 1.4. The sepsis mortality rate decreased from 19.8% in 2013 to 16.3% from January to October 2014 at The Mount Sinai Hospital and from 29% to 19% at Mount Sinai Queens. Additionally, we have vaccinated nearly 16,000 staff members at the Manhattan and Queens campuses against influenza.
The Mount Sinai Hospital was also chosen to be a designated Ebola Treatment Center, one of only 35 such centers nationwide. We constructed a freestanding Biocontainment Unit in Ross Park to care for potential patients, conducted extensive training and simulation exercises, and developed policies and protocols to identify, treat and monitor suspected or confirmed patients with Ebola virus disease or future emerging pathogens.
As we approach 2015, we look forward to further improvements in patient care, safety, quality, and experience as we pursue Joint Commission re-accreditation and many other initiatives. We thank all of you for your dedication to The Mount Sinai Hospital and Mount Sinai Queens and for your commitment to excellence. Please accept our best wishes to you and your families for a happy and healthy New Year.